Dr. Hassan A. Khalil is a thoracic surgeon at Brigham and Women’s Hospital and Dana-Farber Cancer Institute. He specializes in minimally invasive surgical techniques in the treatment of thoracic and foregut diseases, including pleural mesothelioma and lung cancer. He is a certified robotic console surgeon in the da Vinci Xi robotic platform and is also skilled
Dr. David M. Jackman is a thoracic oncologist who is dedicated to improving outcomes for patients diagnosed with lung cancer, pleural mesothelioma, and thymic tumors at the Dana-Farber Cancer Institute. As a physician member of the Lowe Center for Thoracic Oncology, he collaborates with experts across medical disciplines to coordinate and create a plan of
Dr. Petr F. Hausner is a medical oncologist at the University of Maryland Medical Center and the Greenebaum Comprehensive Cancer Center. His clinical specialties are hematology and oncology, thoracic oncology, gastrointestinal oncology, and cutaneous oncology. Working with a multidisciplinary team, he designs treatment plans for patients diagnosed with lung cancer, pleural mesothelioma, and peritoneal mesothelioma,
Dr. Katherine A. Scilla is a medical oncologist at the University of Maryland Medical Center and part of the Greenebaum Comprehensive Cancer Center’s Mesothelioma and Thoracic Oncology Treatment and Research Center Team. She specializes in treating chest and thoracic cancers, including malignant pleural mesothelioma, lung cancer, and thymic cancers. Education and Career Dr. Scilla attended
Mesothelioma is a particularly challenging form of cancer that has proven extremely resistant to traditional treatment protocols. Most patients are offered multimodality treatments that include chemotherapy, and that regimen can lead to a troubling side effect referred to as ‘chemobrain.’ This week researchers have published a study that suggests that it may be caused by
Dr. Jordan D. Miller is a thoracic surgeon and member of the Lung and Thoracic Cancer Team at the University of Kentucky’s UK Markey Cancer Center. He specializes in treating patients with lung cancer, esophageal cancer, pleural mesothelioma, and other conditions, using a variety of high-level techniques, including minimally invasive surgery and video-assisted thoracoscopic surgery.
Dr. Chao H. Huang is a medical oncologist and hematologist at the University of Kansas Medical Center and the University of Kansas Cancer Center. As director of the Lung Cancer Program, he leads a multidisciplinary team in diagnosing and staging patients’ lung cancer and other chest cancers before developing an individual, personalized treatment plan designed
Dr. Kalpaj R. Parekh is an experienced and accomplished cardiothoracic surgeon at the University of Iowa Hospitals and Clinics, as well as the Holden Comprehensive Cancer Center. While his primary interest is in lung transplantation, his clinical efforts and expertise include surgical care of lung cancer and esophageal cancer patients. His technical skills include lung transplant,
Dr. Muhammad Furqan is a medical oncologist and hematologist at the University of Oklahoma Health Stephenson Cancer Center. As a specialist in lung cancer treatment and research, he is a professor and associate section chief for Research in Solid Tumor Oncology. He has been practicing medicine for almost twenty years. Education and Career Dr. Furqan
Dr. Chad E. Denlinger is a thoracic surgeon at Indiana University Health in Indianapolis and a tenured Professor of Surgery at Indiana University School of Medicine. An expert in diseases of the chest, his clinical interests include the treatment of lung cancer and esophageal cancer, advanced lung disease, lung transplant, gastroesophageal reflux disease, cardiothoracic surgery,